SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-23-014018
Filing Date
2023-05-11
Accepted
2023-05-11 20:33:10
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 7756
  Complete submission text file 0001437749-23-014018.txt   9451
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VAXART, INC. 170 HARBOR WAY, STE. 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Lee Phillip E (Reporting) CIK: 0001959565 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35285 | Film No.: 23912806